Donald S. Shepard Schneider Institute for Health Policy

      Homepage       Biography       Publications       Projects       Teaching       Downloads       Links

Chapters in Books and Proceedings


C039. Shepard DS, Halasa YA, Undurraga E. Economic and disease burden of dengue. In: Dengue and Dengue Hemorrhagic Fever, 2nd Edition. Gubler DJ, Ooi EE, Vasudevan S, Farrar J. (eds.). Wallingford, Oxfordshire, UK: CAB International, 2014, Chapter 3, pp. 50-77.

C038. Shepard DS, Suaya JA. Cost-effectiveness of a dengue vaccine in Southeast Asia and Panama: preliminary estimates. In: Handbook of Disease Burdens and Quality of Life Measures, Preedy VR, Watson RR. (Eds.). New York: Springer, 2010, Chapter 73, pp. 1281-1296. Web: http://www.springer.com/medicine/book/978-0-387-78665-0.

C037. Suaya JA, Shepard DS, Beatty M, Farrar J. Disease burden of dengue fever and dengue hemorrhagic fever. In: Handbook of Disease Burdens and Quality of Life Measures, Preedy VR, Watson, RR. (Eds.). New York: Springer, 2010, Chapter 72, pp. 1263-1279. Web: http://www.springer.com/medicine/book/978-0-387-78665-0.

C036. Shepard DS, Suaya JA. Economic evaluation of dengue prevention. In: Economic Evaluation in Child Health, Ungar W. (Editor). Oxford: Oxford University Press, 2009, Chapter 12, pp. 225-237. Web: http://www.oup.com/us/catalog/general/subject/Medicine/PublicHealth/?view=usa&ci=9780199547494

C035. Bhalotra S, Shepard DS. Recruitment into lifestyle modification programmes: a cross-Atlantic perspective. In: Future Public Health: Burdens, Challenges, Opportunities, ed. Dawson S, Morris ZS, Houndmills, Basingstoke, Hampshire, UK: Palgrave Macmillan, Ltd, 2009, pp. 207-229.

C034. Suaya JA, Shepard DS, Beatty ME. Dengue: burden of disease and costs of illness. Working paper 3.2. In: Report of the Scientific Working Group meeting on Dengue, Geneva, 1–5 October 2006 (TDR/SWG/07). Special Programme for Research and Training in Tropical Diseases (TDR). Geneva, Switzerland: WHO, 2007, pp 35-49. Web: www.who.int/tdr.

C033. Hall W, Doran C, Degenhardt L, Shepard DS. Illicit opiate abuse. In: Disease Control Priorities in Developing Countries (2nd Edition), ed. Jamison D, et al., New York: Oxford University Press, DOI: 10.1596/978-0-821-36179-5. Chap. 48, pp 907-932, 2006. Web: http://www.dcp2.org/pubs/DCP/48.

C032. Shepard DS, Neighbors CJ, Lloyd-Richardson EE, Beaston-Blaakman A, Farrell N, Niaura RS. Assessing costs and time of counseling services for HIV+ patients. XIV International AIDS Conference, Barcelona, Spain, July 7-12, 2002, Bologna, Italy: Monduzzi Editore, International Proceedings Division, pp. 119-112 (paper C708s9823).

C031. Callahan JJ Jr, Shepard DS, Beinecke RH, Larson MJ, Cavanaugh D. Mental health and substance abuse treatment in managed care: the Massachusetts Medicaid experience. In: Humane Managed Care, Schamess G, Lightburn A, eds. Washington, DC: National Association of Social Workers Press, 1998, pp. 134-144.

C030. Kongsin S, Cameron CM, Suebsaeng L, Shepard DS. Levels and Determinants of Expenditure on HIV/AIDS in Thailand. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the Developing World. Brussels: World Bank, Chapter 12F, 1998, pp. 297-305.

C029. Tibandebage P, Wangwe S, Mujinja P, Bail RN, Shepard DS. Expenditures on HIV/AIDS in Tanzania. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the Developing World. Brussels: World Bank, Chapter 12E, 1998, pp. 289-296.

C028. Iunes R, Campino AC, Prottas J, Shepard DS. Expenditures on HIV/AIDS in the State of São Paulo, Brazil. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the Developing World. Brussels: World Bank, Chapter 12D, 1998, pp. 273-287.

C027. Izazola J-A, Saavedra J, Prottas J, Shepard DS. Levels and Expenditures on the Treatment and Prevention of HIV/AIDS in Mexico. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the Developing World. Brussels: World Bank, Chapter 12C, 1998, pp. 263-272.

C026. Koné T, Silué A, Agness-Soumahoro J, Bail RN, Shepard DS. Expenditures on AIDS in Côte d'Ivoire. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the Developing World. Brussels: World Bank, Chapter 12B, 1998, pp. 255-262.

C025. Shepard DS. Levels and Determinants of Expenditures on HIV/AIDS in five developing countries: overview. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the Developing World. Brussels: World Bank, Chapter 12A, 1998, pp. 241-253.

C024. Cameron C, Shepard DS, Mulwa J. Caring for persons with AIDS (PWA) in Botswana: is home-based care the answer? In: AIDS in the World II, Mann J, Tarantola DJM, eds. New York: Oxford University Press, 1996, pp. 405-407.

C023. Shepard DS, Vian T, Kleinau EF. Performance of four health insurance programs in rural and urban areas of Zaire [Democratic Republic of the Congo]. In: Financing Health Services through User Fees and Insurance: Case Studies from Sub-Saharan Africa, Shaw RP, Ainsworth M, eds. Africa Technical Department Discussion Paper No. 294. Washington, DC: The World Bank, 1995, pp. 169-206.

C022. Shepard DS. Summary: Approaches to Cost Analysis. In: Cost Analysis Methodology for Clinical Practice Guidelines (AHCPR Publication No. 95-0001), Grady ML, Weiss KA, eds. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services, 1995, pp. 96-100.

C021. Shepard DS, Carrin C, Nyandagazi P. Household participation in financing of health care at government health centers in Rwanda. In: Health Economics Research in Developing Countries, Mills A, Lee K, eds. New York: Oxford University Press, 1993, pp. 140-164. [Also in: Health Economics for Developing Countries, Mills A, Gilson L, eds. London: London School of Hygiene and Tropical Medicine, 1992.]

C020. Shepard DS, Halstead SB. Dengue (with notes on yellow fever and Japanese encephalitis). In: Disease Control Priorities for Developing Countries, Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. New York: Oxford University Press for the World Bank, pp. 303-320, 1993.

C019. Stansfield S, Shepard DS. Acute respiratory infection. In: Disease Control Priorities for Developing Countries, Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. New York: Oxford University Press for the World Bank, pp. 67-90, 1993.

C018. Shepard DS. How the cost of treatments and the costs to patients can be assessed in clinical trials. In: Proceedings: Forum on Emerging Treatments for Breast Cancer, sponsored by the National Cancer Institute. Bethesda, MD: Health Improvement Institute, 1991, pp. 114-119.

C017. Taylor WC, Pass TM, Shepard DS, Komaroff AL. Cost effectiveness of cholesterol reduction for the primary prevention of coronary heart disease in men. In: Preventing Disease: Beyond the Rhetoric, Goldbloom RB, Lawrence RS, eds. New York: Springer-Verlag, 1990, pp. 437-441.

C016. Shepard DS. Cost of AIDS in a developing area: Indirect and direct cost of AIDS in Puerto Rico. In: Economic Aspects of AIDS and HIV Infection, Schwefel D, Leidi R, Rovira J, Drummond MF, eds., New York: Springer-Verlag, 1990, pp. 226-237.

C015. Shepard DS, Cameron CSM, Robbins M, Pollack M. Economic and logistic impacts of temperature-sensitive vaccines. In: Temperature Stable Vaccines for Developing Areas. Washington, DC: National Academy Press, 1989, pp. 36-83.

C014. Shepard DS, Benjamin ER. User fees and health financing in developing countries: mobilizing financial resources for health. In: Health, Nutrition and Economic Crises: Approaches to Policy in the Third World, Bell DE, Reich MR, eds. Dover, MA: Auburn House Publishing, 1988.

C013. Meister SJ, Shepard DS, Zeckhauser RJ. Cost-effectiveness of prenatal screening for neural tube defects. In: Prenatal Screening, Policies, and Values: The Example of Neural Tube Defects, Nightingale EO, Meister SB, eds. Cambridge, MA: Division of Health Policy Research and Education, Harvard University, 1987, pp. 66-93.

C012. Shepard DS, Meister SJ, Zeckhauser RJ. Screening for neural tube defects: an application of decision analysis. In: Health interventions and population heterogeneity: evidence from Japan and the U.S. NIRA Output NRF-83-1. Tokyo, Japan: National Institute for Research Advancement, 1985, pp. 69-89. (Presented at Mead-Johnson Symposium, Vail, Colorado, June 10-14, 1984.)

C011. Shepard DS. Costs and financing of oral rehydration therapy (ORT). In: Infant and Child Survival Technologies (Annual Technical Update No. 1) prepared by the Technologies for Primary Health Care Project (PRITECH). Washington, DC: US Agency for International Development, 1984, pp. 43-50.

C010. Shepard DS. Procedures for assessing the cost-effectiveness of a diarrheal disease control program based on oral rehydration therapy. In: Proceedings of the International Conference on Oral Rehydration Therapy. Washington, DC: US Agency for International Development, 1984, pp. 128-130.

C009. Shepard DS. Computer mapping: the SYMAP interpolation algorithm. In: Spatial Statistics and Models, Gaile GL, Willmott CJ, eds. Dordrecht, Netherlands: D. Reidel Publishing Company, 1984, pp. 133-145.

C008. Shepard DS, Zeckhauser RJ. Life-cycle consumption and willingness to pay for increased survival. In: Value of Life and Safety, Jones-Lee MW, ed. Amsterdam: North Holland, 1982, pp. 95-141. (Presented at the Geneva Conference on the Value of Life and Safety, sponsored by the International Association for the Study of Insurance Economics. Geneva, Switzerland, March 30-April 1, 1981.)

C007. Shepard DS, Zeckhauser RJ. The choice of health policies with heterogeneous populations. In: Economic Aspects of Health, Fuchs VR, ed. Chicago: University of Chicago Press, 1982, pp. 255-297.

C006. Shepard DS. Hospital closures: modeling their impact on medical costs. In: Systems Science in Health Care: Proceedings of the International Conference on Systems Science in Health Care, Held in Montreal, July 14-17, 1980, Tilquin C, ed. New York: Pergamon, 1981, vol. 1, pp. 235-248.

C005. Zeckhauser RJ, Shepard DS. Principles for saving and valuing lives. In: The Benefits of Health and Safety Regulation, Ferguson AR, LeVeen EP, eds. Cambridge, MA: Ballinger Publishing Co, 1981, pp. 91-130. Republished in Technological Risk Assessment, Ricci P, Sagan L, Whipple L, eds. The Hague, Netherlands: Martinus Nijhoff, 1983.

C004. Shepard DS. The wait to see the doctor: an application of exploratory data analysis. In: Statistics and Public Policy, Fairley WB, Mosteller F, eds. Reading, MA: Addison Wesley, 1977, pp. 87-109.

C003. Shepard DS, Zeckhauser RJ. Heterogeneity as a factor in surgical decision making. In: Costs, Risks and Benefits of Surgery, Bunker JP, Barnes BA, Mosteller F, eds. New York: Oxford University Press, 1977, pp. 56-69.

C002. Stason WB, Weinstein MC, Shepard DS. Obstacles to controlling hypertension. In: Hypertension: A Policy Perspective by Weinstein MC. and Stason WB. Cambridge, MA: Harvard University Press, 1976, pp. 111-139.

C001. Shepard DS. A two-dimensional interpolation function for irregularly spaced data. Proceedings of 23rd National Conference, Association for Computing Machinery. Princeton, NJ: Brandon/Systems Press, 1968, pp. 517-524.



Back to Top   |   Updated 17 March 2016 |   Created by Jeremy Maitin-Shepard